Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies

E-ISSN： 1873-5576|18|2|202-208

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.2, 2018-01, pp. : 202-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory Aspects of Oncolytic Virus Products

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 203-208

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Current Cancer Drug Targets, Vol. 18, Iss. 2, 2018-01 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 422-427

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Virus Therapy - Foreword

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 123-125

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical trials involving the oncolytic virus, reovirus: ready for prime time?

By Black Allison J Morris Don G

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 517-520

Informa Healthcare

Access to resources Recommend Favorite